Cargando…

Twenty Years of Advancements in a Radiotherapy Facility: Clinical Protocols, Technology, and Management

Background: Hypo-fractionation can be an effective strategy to lower costs and save time, increasing patient access to advanced radiation therapy. To demonstrate this potential in practice within the context of temporal evolution, a twenty-year analysis of a representative radiation therapy facility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomatis, Stefano, Mancosu, Pietro, Reggiori, Giacomo, Lobefalo, Francesca, Gallo, Pasqualina, Lambri, Nicola, Paganini, Lucia, La Fauci, Francesco, Bresolin, Andrea, Parabicoli, Sara, Pelizzoli, Marco, Navarria, Pierina, Franzese, Ciro, Lenoci, Domenico, Scorsetti, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378035/ https://www.ncbi.nlm.nih.gov/pubmed/37504370 http://dx.doi.org/10.3390/curroncol30070510

Ejemplares similares

Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors
por: Fogliata, Antonella, et al.
Publicado: (2022)

Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk
por: Franzese, Ciro, et al.
Publicado: (2023)

In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study
por: Mancosu, Pietro, et al.
Publicado: (2015)

MLC parameters from static fields to VMAT plans: an evaluation in a RT-dedicated MC environment (PRIMO)
por: Paganini, Lucia, et al.
Publicado: (2019)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
por: Scorsetti, Marta, et al.
Publicado: (2018)

RapidPlan head and neck model: the objectives and possible clinical benefit
por: Fogliata, A., et al.
Publicado: (2017)

Evaluation of plan complexity and dosimetric plan quality of total marrow and lymphoid irradiation using volumetric modulated arc therapy
por: Lambri, Nicola, et al.
Publicado: (2023)

Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients
por: Alongi, Filippo, et al.
Publicado: (2012)

Automatic planning of the lower extremities for total marrow irradiation using volumetric modulated arc therapy
por: Lambri, Nicola, et al.
Publicado: (2022)

Enhancing Radiotherapy Workflow for Head and Neck Cancer with Artificial Intelligence: A Systematic Review
por: Franzese, Ciro, et al.
Publicado: (2023)

Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case
por: Lobefalo, Francesca, et al.
Publicado: (2013)

Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study
por: Alongi, Filippo, et al.
Publicado: (2013)

Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery
por: Franzese, Ciro, et al.
Publicado: (2017)

Anatomy driven optimization strategy for total marrow irradiation with a volumetric modulated arc therapy technique
por: Mancosu, Pietro, et al.
Publicado: (2012)

Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer
por: Loi, Mauro, et al.
Publicado: (2020)

Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform
por: Scorsetti, Marta, et al.
Publicado: (2023)

RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies
por: Fogliata, A., et al.
Publicado: (2019)

Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients
por: Franceschini, Davide, et al.
Publicado: (2022)

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience
por: Tozzi, Angelo, et al.
Publicado: (2013)

Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation
por: Dei, Damiano, et al.
Publicado: (2023)

Cone beam CT pre‐ and post‐daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer
por: Reggiori, Giacomo, et al.
Publicado: (2010)

Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma
por: Cozzi, Luca, et al.
Publicado: (2019)

Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment
por: Lambri, Nicola, et al.
Publicado: (2023)

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy
por: Franzese, Ciro, et al.
Publicado: (2015)

Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study
por: Navarria, Pierina, et al.
Publicado: (2023)

Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations
por: Mancosu, Pietro, et al.
Publicado: (2012)

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)
por: Comito, Tiziana, et al.
Publicado: (2023)

Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments
por: Scorsetti, Marta, et al.
Publicado: (2011)

Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy
por: Navarria, Pierina, et al.
Publicado: (2016)

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation
por: Cozzi, Luca, et al.
Publicado: (2020)

Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment
por: Franzese, Ciro, et al.
Publicado: (2021)

Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results
por: De Rose, Fiorenza, et al.
Publicado: (2016)

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge
por: Navarria, Pierina, et al.
Publicado: (2016)

Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy
por: Tozzi, Angelo, et al.
Publicado: (2014)

Performance of a Knowledge-Based Model for Optimization of Volumetric Modulated Arc Therapy Plans for Single and Bilateral Breast Irradiation
por: Fogliata, Antonella, et al.
Publicado: (2015)

Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy
por: Cozzi, Luca, et al.
Publicado: (2017)

The impact of scanning data measurements on the Acuros dose calculation algorithm configuration
por: Fogliata, A., et al.
Publicado: (2020)

Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma
por: Cozzi, Luca, et al.
Publicado: (2018)

The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer
por: Franzese, Ciro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_in8m9ao5lophdj05uack7oor5e